Lilly France: Alert satisfies the draconian standards of the pharmaceutical group
 Lilly: 125 years of growth through innovation
Lilly, the world’s 11th largest pharmaceutical group, bases its development on the discovery of innovative medicines: from the very first industrial production of insulin in 1923 to the development of products stemming from genetic engineering, the company’s aim has always been to market products that are the first or best in their therapeutic class. Lilly employs 44,000 people around the world, with a presence in over 150 countries, and has 20 production sites and 9 research and development centres on all 5 continents.
|
|
Read more...
|
|
|
|
|
|
|
Pharmaceutical
